Showing results (71-80 of 1,337) with videos related to

Sort By:
Pageof 134
Neuro-Oncology Advances|November 26, 2020
Epidemiology of vestibular schwannoma in the United States, 2004-2016Gino Cioffi, Debra N Yeboa, Michael Kelly, et al.
Neuro-Oncology Advances|December 11, 2020
Malignant transformation of WHO grade I meningiomas after surgery or radiosurgery: systematic review and meta-analysis of observational studiesSatoshi Nakasu, Akifumi Notsu, Kiyong Na, et al.
Neuro-Oncology Advances|December 11, 2020
HER2-targeted therapy prolongs survival in patients with HER2-positive breast cancer and intracranial metastatic disease: a systematic review and meta-analysisAnders W Erickson, Farinaz Ghodrati, Steven Habbous, et al.
Neuro-Oncology Advances|March 19, 2021
Factors affecting time to brain metastases for stage 2 and 3 breast cancer patients: A large single-institutional analysis with potential screening implicationsToni Q Cao, Karan Dixit, Cesar Santa-Maria, et al.
Neuro-Oncology Advances|March 19, 2021
A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4-10 brain metastasesDianne Hartgerink, Anna Bruynzeel, Danielle Eekers, et al.
Neuro-Oncology Advances|January 28, 2021
Clinical correlates for immune checkpoint therapy: significance for CNS malignanciesNivedita M Ratnam, Stephen C Frederico, Javier A Gonzalez, et al.
Neuro-Oncology Advances|March 8, 2021
Multiple positron emission tomography tracers for use in the classification of gliomas according to the 2016 World Health Organization criteriaKeisuke Miyake, Kenta Suzuki, Tomoya Ogawa, et al.
Neuro-Oncology Advances|February 1, 2021
Introduction to radiomics and radiogenomics in neuro-oncology: implications and challengesNiha Beig, Kaustav Bera, Pallavi Tiwari
Neuro-Oncology Advances|February 1, 2021
Feature-based PET/MRI radiomics in patients with brain tumorsPhilipp Lohmann, Anna-Katharina Meißner, Martin Kocher, et al.
Neuro-Oncology Advances|January 7, 2022
Quantitative cerebrospinal fluid circulating tumor cells are a potential biomarker of response for proton craniospinal irradiation for leptomeningeal metastasisN Ari Wijetunga, Adrienne Boire, Robert J Young, et al.
Pageof 134